Use of VX-702 for treating rheumatoid arthritis

Details for Australian Patent Application No. 2007223901 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Kadiyala, Irina; Godfrey, Christopher; Kauffman, Robert; Mohanlal, Ramon; Alam, John

Agent Cullen & Co

Pub. Number AU-A-2007223901

PCT Pub. Number WO2007/103468

Priority 60/780,277 08.03.06 US; 60/779,862 07.03.06 US

Filing date 7 March 2007

Wipo publication date 13 September 2007

International Classifications

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

2 October 2008 PCT application entered the National Phase

  PCT publication WO2007/103468 Priority application(s): WO2007/103468

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007223903-Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

2007223896-Coaxial connector including clamping ramps and associated method